심장 모니터링 및 심장박동 관리 시장 : 제품별, 최종 사용자별 - 세계 예측(2024-2030년)

[196 Pages Report] The Cardiac Monitoring & Cardiac Rhythm Management Market size was estimated at USD 19.80 billion in 2023 and expected to reach USD 20.74 billion in 2024, at a CAGR 4.91% to reach USD 27.71 billion by 2030.

Cardiac monitoring & cardiac rhythm management are essential areas of healthcare that focus on evaluating and managing the heart's electrical activities and rhythms. These techniques are crucial for diagnosing and treating patients with heart conditions such as arrhythmias, heart attacks, and other cardiovascular issues. The increase in cardiovascular diseases, especially among aging populations, is expanding the need for cardiac monitoring & cardiac rhythm management solutions. Rising improvements and expansions in healthcare infrastructure, especially in emerging countries, enable more people to access cardiac care technologies, thus broadening the market. The high cost of cardiac monitoring & rhythm management devices and availability of technical challenges with cardiac monitoring & cardiac rhythm management devices hampers the market growth. Rising innovations such as wireless and remote monitoring technologies allow patients to receive continuous care without staying in a hospital are expected ro create opportunities for market growth. These advancements make it easier for healthcare providers to monitor patients and adjust treatments in real-time.

Regional Insights

The Americas region holds a substantial growth in the cardiac monitoring & cardiac rhythm management market due to presence of advanced healthcare infrastructure, high prevalence of cardiovascular diseases, and the presence of leading medical device companies. Moreover, the adoption of technologies such as wireless and remote monitoring, along with a focus on healthcare advancements and significant healthcare spending in the U.S., Brazil, Mexico, and Canada, contributes to the robust growth in this region. The APAC region is marked by a rapid growth rate in the cardiac monitoring & cardiac rhythm management market, driven by factors such as the increasing aging population, growing prevalence of lifestyle diseases, and rising healthcare expenditure. Countries such as China, Japan, and India are experiencing significant growth due to improvements in healthcare infrastructure, rising disposable incomes, and governmental initiatives aimed at modernizing healthcare. Europe is a major contributor to the EMEA region's market because of its strong healthcare systems, high healthcare spending, and stringent regulations ensuring high-quality standards. The Middle East and Africa are expected to experience growth influenced by economic disparities and varying levels of access to healthcare facilities.

Market Insights

• Market Dynamics

The market dynamics represent an ever-changing landscape of the Cardiac Monitoring & Cardiac Rhythm Management Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

• Market Drivers
  • Increasing geriatric population and incidence of cardiovascular diseases
  • Favorable government regulations and availability of reimbursement for CRM
  • Growing awareness towards early diagnosis and preventive healthcare measures

• Market Restraints
  • High cost associated with cardiac monitoring and rhythm management devices

• Market Opportunities
  • Increasing proclivity for wearable cardiac monitoring devices
  • Ongoing development for advanced cardiac devices

• Market Challenges
  • Lack of skilled professionals with expertise in electrocardiography and cardiac rhythm
• Market Segmentation Analysis
  • Product: Growing usage of cardiac monitoring devices for treating heart-related conditions
  • End-User: High need for cardiac monitoring & cardiac rhythm management across hospitals for providing advanced care

• Market Disruption Analysis
• Porter's Five Forces Analysis
• Value Chain & Critical Path Analysis
• Pricing Analysis
• Technology Analysis
• Patent Analysis
• Trade Analysis
• Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Cardiac Monitoring & Cardiac Rhythm Management Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Cardiac Monitoring & Cardiac Rhythm Management Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Abbott's Assert-IQ Cardiac Monitor Receives CE Mark Approval for Enhanced Heart Rhythm Management

Abbott received CE mark approval in Europe for Assert-IQ, an advanced insertable cardiac monitor capable of remotely tracking heart rhythms for up to six years. Equipped with Bluetooth technology, the device facilitates the detection and recording of irregular heartbeats, such as elusive atrial fibrillation episodes, and provides critical data alerts to clinicians to support optimal treatment decisions. [Published On: 2024-03-26]

FDA Approves Medtronic's Innovative Aurora EV-ICD System

Medtronic plc has secured FDA approval for its groundbreaking Aurora EV-ICD MRI SureScan system and associated Epsila EV MRI SureScan defibrillation lead. This advanced technology marks a significant innovation by incorporating the life-saving functionalities of conventional implantable cardioverter-defibrillators while strategically positioning the lead under the breastbone, external to the heart and veins. This arrangement allows the Aurora EV-ICD to deliver vital defibrillation, anti-tachycardia pacing, and preventative backup pacing, maintaining traditional devices' familiar size and durability. [Published On: 2023-09-23]

Advancements in Cardiac Monitoring: The Introduction of Boston Scientific's LUX-Dx II+ ICM System

Boston Scientific introduced the LUX-Dx II+ Insertable Cardiac Monitor (ICM) System, an advanced solution for continuous arrhythmia monitoring in patients with conditions such as atrial fibrillation, cryptogenic stroke, and syncope. This innovative device features a dual-stage algorithm that initially detects and subsequently verifies arrhythmias, ensuring only clinically relevant data prompts alerts to healthcare providers. The system's remote programming capabilities enhance patient comfort by adjusting event detection settings and symptom recording without the need for face-to-face visits, streamlining the management process and supporting timely, informed clinical decisions. [Published On: 2023-09-03]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Cardiac Monitoring & Cardiac Rhythm Management Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Cardiac Monitoring & Cardiac Rhythm Management Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, ACS Diagnostics by Applied Cardiac Systems Inc., Alivecor, Inc., Asahi Kasei Corporation, Baxter International Inc., Biotronik SE & Co KG, Boston Scientific Corporation, BPL Medical Technologies Private Limited, GE Healthcare, HeartFlow Holding, Inc., Koninklijke Philips N.V.,, Lepu Medical Technology(Beijing)Co.,Ltd., Medtronic PLC, Microport Scientific Corporation, Nihon Kohden Corporation, Qardio, Inc., Schiller AG, Spandan, Tricog Health, and Zoll Medical Corporation.

Market Segmentation & Coverage

This research report categorizes the Cardiac Monitoring & Cardiac Rhythm Management Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Product
  • Cardiac Monitoring Devices
    • ECG
      • Holter Monitors
      • Resting ECG
      • Stress ECG

• Echocardiogram
• Event Monitors
• Implantable Loop Recorders
• Mobile Cardiac Telemetry

• Cardiac Rhythm Management Devices
  • Defibrillators
    • External Defibrillator
    • Automatic External Defibrillator

Manual External Defibrillator

Wearable Cardioverter Defibrillator

• Implantable Cardioverter Defibrillators
• S-ICD

T-ICD

• Loop Recorders
• Pacemaker
  • External
  • Implantable
• End-User
  • Ambulatory Center
  • Home Healthcare
  • Hospitals

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam

• Europe, Middle East & Africa
  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing geriatric population and incidence of cardiovascular diseases
    • 5.1.1.2. Favorable government regulations and availability of reimbursement for CRM
    • 5.1.1.3. Growing awareness towards early diagnosis and preventive healthcare measures
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with cardiac monitoring and rhythm management devices
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing proclivity for wearable cardiac monitoring devices
    • 5.1.3.2. Ongoing development for advanced cardiac devices
  • 5.1.4. Challenges
    • 5.1.4.1. Lack of skilled professionals with expertise in electrocardiography and cardiac rhythm
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Growing usage of cardiac monitoring devices for treating heart-related conditions
  • 5.2.2. End-User: High need for cardiac monitoring & cardiac rhythm management across hospitals for providing advanced care
• 5.3. Market Disruption Analysis
• 5.4. Porter's Five Forces Analysis
  • 5.4.1. Threat of New Entrants
  • 5.4.2. Threat of Substitutes
  • 5.4.3. Bargaining Power of Customers
  • 5.4.4. Bargaining Power of Suppliers
  • 5.4.5. Industry Rivalry
• 5.5. Value Chain & Critical Path Analysis
• 5.6. Pricing Analysis
• 5.7. Technology Analysis
• 5.8. Patent Analysis
• 5.9. Trade Analysis
• 5.10. Regulatory Framework Analysis

6. Cardiac Monitoring & Cardiac Rhythm Management Market, by Product

• 6.1. Introduction
• 6.2. Cardiac Monitoring Devices
• 6.3. Cardiac Rhythm Management Devices

7. Cardiac Monitoring & Cardiac Rhythm Management Market, by End-User

• 7.1. Introduction
• 7.2. Ambulatory Center
• 7.3. Home Healthcare
• 7.4. Hospitals

8. Americas Cardiac Monitoring & Cardiac Rhythm Management Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Cardiac Monitoring & Cardiac Rhythm Management Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Cardiac Monitoring & Cardiac Rhythm Management Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
  • 11.3.1. Abbott's Assert-IQ Cardiac Monitor Receives CE Mark Approval for Enhanced Heart Rhythm Management
  • 11.3.2. FDA Approves Medtronic's Innovative Aurora EV-ICD System
  • 11.3.3. Advancements in Cardiac Monitoring: The Introduction of Boston Scientific's LUX-Dx II+ ICM System
• 11.4. Strategy Analysis & Recommendation

12. Competitive Portfolio

• 12.1. Key Company Profiles
• 12.2. Key Product Portfolio